Risks for Retrograde Type-A Dissection After TEVAR
|
|
|
- Shanna Tucker
- 6 years ago
- Views:
Transcription
1 Risks for Retrograde Type-A Dissection After TEVAR Frank R. Arko, III, MD Chief, Vascular and Endovascular Surgery Professor, Cardiovascular Surgery Co-Director, Aortic Institute Sanger Heart and Vascular Institute Charlotte, NC
2 Retrograde Type-A Dissection After TEVAR TEVAR has shown to be an effective and durable repair option in the treatment of thoracic aortic pathology Retrograde Type A dissection (RTAD) following TEVAR remains a highly lethal complication Nearly two-thirds of the RTAD cases present within the first month RTAD risk factors as described in literature are: Device Oversizing (>20%) Large Stent Graft Diameter Proximal Landing Zone Ascending Aortic Diameter (> 40mm) Gender Ballooning/Iatrogenic injury Smoking Arch Angulation and STJ Dilation 1. Hogendoorn W, Hunink MG, Schlosser FJ, Moll FL, Sumpio BE, Muhs BE. Endovascular vs: open repair of complicated acute type B aortic dissections. J Endovasc Ther 2014;21: Makaroun MS, Dillavou ED, Wheatley GH, Cambria RP, Gore TAGI. Five-year results of endovascular treatment with the Gore TAG device compared with open repair of thoracic aortic aneurysms. Journal of Vascular Surgery 2008;47: Canaud L, Ozdemir BA, Patterson BO, et al: Retrograde aortic dissection after thoracic endovascular aortic repair. Ann Surg 2014;260(2):
3 Retrograde Type-A Timing Intra op 20.9% <30d 50.0% >30d 29.1% Over 70% occur within the first 30-days Delayed onset suggests disease progression 37% overall mortality Canaud et al. Ann Surg 2014;00:1-7 Range: days
4 Hata M, Shiono M, Inoue T, Sezai A, Niino T, Negishi N, Sezai Y. Optimal treatment of type B acute aortic dissection: long-term medical follow-up results. Ann Thorac Surg. 2003;75: Pathology Treated Patients treated for Aortic Dissection have the highest pooled rates of RTAD 4 Acute TBAD had the highest associated rate for RTAD at 8.4% Chronic TBAD associated rate for RTAD at 3% The influence of acute dissection and aortic fragility on RTAD has been illustrated in other reports 5 Retrograde Type A Aortic Dissection After Thoracic Endovascular Aortic Repair: A Systematic Review and Meta-Analysis Yanqing Chen, MD;* Simeng Zhang, MD;* Lei Liu, MD;* Qingsheng Lu, MD; Tianyi Zhang, MD; Zaiping Jing, MD
5 Landing Zone and RTAD Landing Zone RTAD (%) OR (relative to zones 3/4) RTAD rates vary significantly based on zone 6 Significantly higher in Zones % during zone 0 total debranching 7 Significant correlation between pathology, zone and repair complexity / Canaud et al. Ann Surg 2014;00:1-7 Czerny M, Weigang E, Sodeck G, et al. Targeting landing zone 0 by total arch rerouting and TEVAR: midterm results of a transcontinental registry. Ann Thorac Surg. 2012;94:84 89
6 Device Oversizing Patients with RTAD had significantly greater device oversizing % vs. 10.3% (p<0.0001) Each 1% oversizing above 9% Increase in OR of RTAD - 14% (p<0.0001) Device Oversizing in TBAD resulted in a higher RTAD rate % vs 14.1% Canaud et al. Ann Surg 2014;00:1-7
7 Ascending Arch Condition Several arch characteristics for RTAD Enlarged aortic diameter >40mm (4.8% vs 0.9%; P =.047) 9 Bicuspid valve Presence of angulated (>60 ) Gothic arch type Abnormal aortic root morphology 10 o Valsalva diameter >40mm (33% vs 15%, P ¼.31) o Loss of STJ (> diameter of aortic root) Williams JB, Andersen ND, Bhattacharya SD, et al. Retrograde ascending aortic dissection as an early complication of thoracic endovascular aortic repair. J Vasc Surg. 2012;55: Factors favoring retrograde aortic dissection after endovascular aortic arch repair Thomas Gandet, MD, Ludovic Canaud, MD, PhD, Baris Ata Ozdemir, MBBS, Vincent Ziza, MD, Roland Demaria, MD, PhD, Bernard Albat, MD, PhD, and Pierre Alric, MD, PhD; (J Thorac Cardiovasc Surg 2015;150:136-42)
8 Proximal Configuration No significant differences between the proximal configuration of devices 2.8% Proximal Bare Stent (48/1724) VS 2.4% NBS, p= (28/1159) Zone placement and dynamic arch motion may also play a role
9 RTAD Experience at Carolinas Medical Center Retrospective review of TBAD treated with TEVAR ( ) 186 patients; Mean follow-up 569 days Overall incidence of RTAD 8.0% (15/186) Number Presentation (Days) Percentage 1 Intra-Op 0.5% % % %
10 Demographics and Comorbidities Variable; n (%)/ Mean (SD) RTAD (n-15) Non-RTAD (n-171) P-value Male Sex 8 (46.7) 0.6 Age 61.5 (14.4) 0.9 Race 0.5 African-American 8 (53.3) 72 (42.1) White 7 (46.7) 94 (55.0) CAD 1 (6.7) 45 (26.3) 0.1 CKD/CRI 3 (20.0) 44 (25.7) 0.8 COPD 1 (6.7) 36 (21.1) 0.3 Diabetes 1 (6.7) 30 (17.5) 0.5 HLD 6 (40.0) 71 (41.5) 0.9 HTN 13 (86.7) 160 (93.6) 0.3 Smoking < 1yr 7 (46.7) 85 (49.7) 0.8 Marfans 1 (6.7) 5 (2.9) 0.4 Other Genetic/Connective Tissue 0 (0) 2 (1.2) 1.0 Previous Ascending/Arch Repair 2 (13.3) 11 (6.4) 0.3
11 Indication for Intervention Procedural Indication RTAD (n - 15) Non-RTAD (n 171) Acute Complicated 8 (53.3) 50 (29.2) Acute High Risk 3 (20.0) 69 (40.8) Acute Uncomplicated 2 (13.3) 17 (9.9) Chronic 2 (13.3) 35 (20.5) Variable n(%) or Mean (SD) RTAD (n = 15) Non-RTAD (n = 171) P-value Mesenteric Ischemia 2 (13.3) 8 (4.7) 0.2 Renal Ischemia 6 (40.0) 29 (17.0) 0.04 Lower Limb Ischemia 1 (6.7) 11 (6.4) 1.0 Spinal Ischemia 1 (6.7) 3 (1.8) 0.3 Aneurysm (> 6cm) 0 (0.0) 4 (2.3) 1.0 Rupture 1 (6.7) 6 (3.5) 0.5 High Risk: Refractory HTN 0 (0.0) 11 (6.4) 0.6 High Risk: Continued Pain 2 (13.3) 32 (18.7) 1.0 High Risk: Pain and HTN 1 (6.7) 23 (13.5) 0.7
12 Intervention Timing Variable; n(%) or mean(sd) RTAD (n=15) No RTAD (n=171) p-value Acute (less than two weeks) Presentation 10 (66.7) 94 (55.6) 0.4 Time to Intervention 0.4 Acute Early (<48 hours) 1 (6.7) 30 (17.5) Acute Delayed (48 hrs-2 weeks) 9 (60) 64 (37.4) Subacute (2-6 weeks) 1 (6.67) 19 (11.1) Chronic 4 (26.7) 56 (32.8) Unknown 0 (0) 2 (1.2)
13 Aorta Characteristics Mean (SD); Frequency (%) RTAD (n=15) No-RTAD (n=171) P-value Ascending Diameter 37.1 (4.9) 36.4 (4.3) 0.5 Ascending > 4cm 7 (46.7) 35 (21.5) 0.05 Arch Type 0.6 Type I 6 (40.00) 49 (28.99) Type II 3 (20.00) 53 (31.36) Type III 6 (40.00) 67 (39.64) Bovine 5 (33.33) 49 (28.65) 0.8 Dissection proximal to LSA 5 (33.3) 26 (15.3) 0.1 Presence of IMH 10 (66.67) 65 (38.01) 0.03 IMH in Arch 3 (20.00) 12 (7.02) 0.1
14 Procedural Details Variable; n(%) or mean(sd) RTAD (n=15) No RTAD (n=171) p-value Proximal Landing Zone (93.3) 109 (63.7) 0.02 Zone 0 1 (6.7) 2 (1.17) Zone 1 4 (26.7) 8 (4.68) Zone 2 9 (60.0) 99 (57.9) Zone 3 1 (6.7) 44 (25.7) Zone (0.0) 18 (10.6) Struts at most proximal attachment 11 (73.3) 124 (77.5) 0.7 Graft oversizing (based on CTA) 4.6 (6.1) 5.4 (6.9) 0.2 Diameter of most proximal graft 33.3 (3.3) 31.8 (4.1) 0.1 Length of most proximal graft (25.8) (35.1) 0.2 Number of stent grafts in thoracic aorta 1.8 (0.4) 1.7 (0.7) 0.2 Number of stents in visceral arteries 0.7 (1.0) 0.3 (0.8) 0.05 Had stents placed in visceral arteries 5 (33.3) 26 (15.2%) 0.1
15 Case Review Patient Presentation Snorkel repair of LSA and LCA with TEVAR in 2011 Routine follow-up (2 year) with a Type A dissection and occlusion of LSA stent Non-operative candidate for standard repair of ascending arch Additional snorkel of innominate artery and placement of graft decided as treatment plan
16 Initial Angiogram Type A Dissection
17 Device Placement
18 Final Angiogram
19 Minimizing Risks for RTAD Careful patient presentation BEFORE determining treatment approach Establish a systematic protocol to minimize threat of RTAD Iatrogenic injury is REAL - minimize manipulation and wire/catheter movement Size appropriately based on pathology and treatment zone Use IVUS for all aortic procedures
20 Conclusions The occurrence of RTAD after TEVAR remains relatively infrequent but devastating Several risk factors influence risks for RTAD: Pathology Anatomy, Procedural techniques Device selection Continued Cocaine Use Oversizing Treatment timing Acute Complicated TBAD Ischemia of Visceral/Renal Arteries At risk patients for RTAD may require enhanced surveillance Additional R & D and investigation must continue to further reduce the risk of RTAD
21 Thank You Frank R. Arko, III, MD Chief, Vascular and Endovascular Surgery Professor, Cardiovascular Surgery Co-Director, Aortic Institute Sanger Heart and Vascular Institute Charlotte, NC
Endovascular therapy for Ischemic versus Nonischemic complicated acute type B aortic dissection (catbad).
Endovascular therapy for Ischemic versus Nonischemic complicated acute type B aortic dissection (catbad). AS. Eleshra, MD 1, T. Kölbel, MD, PhD 1, F. Rohlffs, MD 1, N. Tsilimparis, MD, PhD 1,2 Ahmed Eleshra
Jean M Panneton, MD Professor of Surgery Program Director Vascular Surgery Chief EVMS. Arch Pathology: The Endovascular Era is here
Jean M Panneton, MD Professor of Surgery Program Director Vascular Surgery Chief EVMS Arch Pathology: The Endovascular Era is here Disclosures Consultant: Cook Medical, Bolton Medical, Medtronic Inc, Volcano,
Optimal Treatment of Chronic Dissection
Optimal Treatment of Chronic Dissection Chun-Che Shih 施俊哲 MD, Ph.D. Chief, Professor Institute of Clinical Medicine National Yang Ming University Division of Cardiovascular Surgery Taipei Veterans General
Endovascular Management of Thoracic Aortic Pathology Stéphan Haulon, J Sobocinski, B Maurel, T Martin-Gonzalez, R Spear, A Hertault, R Azzaoui
Endovascular Management of Thoracic Aortic Pathology Stéphan Haulon, J Sobocinski, B Maurel, T Martin-Gonzalez, R Spear, A Hertault, R Azzaoui Aortic Center, Lille University Hospital, France Disclosures
Technique and Outcome of Laser Fenestration For Arch Vessels
Technique and Outcome of Laser Fenestration For Arch Vessels Jean M. Panneton MD, FRCSC, FACS Professor of Surgery Chief & Program Director Division of Vascular Surgery Eastern Virginia Medical School
Development of a Branched LSA Endograft & Ascending Aorta Endograft
Development of a Branched LSA Endograft & Ascending Aorta Endograft Frank R. Arko III, MD Sanger Heart & Vascular Institute Carolinas Medical Center Charlotte, North Carolina, USA Disclosures Proximal
The Petticoat Technique Managing Type B Dissection with both Early and Long Term Considerations
The Petticoat Technique Managing Type B Dissection with both Early and Long Term Considerations Joseph V. Lombardi, MD Professor & Chief, Division of Vascular & Endovascular Surgery Department of Surgery,
Objective assessment of current stent grafts: which graft for which lesion. Ludovic Canaud, MD, PhD Pierre Alric, MD, PhD Montpellier, France
Objective assessment of current stent grafts: which graft for which lesion Ludovic Canaud, MD, PhD Pierre Alric, MD, PhD Montpellier, France Conflict of interest: none 1 Introduction Different diseases
How to achieve a successful proximal sealing in TEVAR? Pr L Canaud
How to achieve a successful proximal sealing in TEVAR? Pr L Canaud CHU de Montpellier France Disclosure I have the following potential conflicts of interest to report: Consulting: Medtronic. Proximal neck
TEVAR. (Thoracic Endovascular Aortic Repair) for Aneurysm and Dissection. Bruce Tjaden MD Vascular Surgery Fellow
Department of Cardiothoracic & Vascular Surgery McGovern Medical School / The University of Texas Health Science Center at Houston TEVAR (Thoracic Endovascular Aortic Repair) for Aneurysm and Dissection
I-Hui Wu, M.D. Ph.D. Clinical Assistant Professor Cardiovascular Surgical Department National Taiwan University Hospital
Comparisons of Aortic Remodeling and Outcomes after Endovascular Repair of Acute and Chronic Complicated Type B Aortic Dissections I-Hui Wu, M.D. Ph.D. Clinical Assistant Professor Cardiovascular Surgical
Total Endovascular Repair Type A Dissection. Eric Herget Interventional Radiology
Total Endovascular Repair Type A Dissection Eric Herget Interventional Radiology 65 year old male Acute Type A Dissection Severe Aortic Regurgitation No co-morbidities Management? Part II Evolving Global
Global Evidence for the Treatment of Type B Aortic Dissection
Global Evidence for the Treatment of Type B Aortic Dissection Ross Milner, MD Professor of Surgery Director, Center for Aortic Diseases September 17, 2016 Disclosures Consultant Cook, Endospan, Medtronic,
No Disclosure. Aortic Dissection in Japan. This. The Challenge of Acute and Chronic Type B Aortic Dissections with Endovascular Aortic Repair
No Disclosure The Challenge of Acute and Chronic Type B Aortic Dissections with Endovascular Aortic Repair Toru Kuratani Department of Cardiovascular Surgery Osaka University Graduate School of Medicine,
Distal Arch and Descending Aorta: What Is the Optimal Therapy in 2017?
Distal Arch and Descending Aorta: What Is the Optimal Therapy in 2017? Eric E. Roselli, MD Chief, Adult Cardiac Surgery Director, Aorta Center Heart and Vascular Institute, Cleveland Clinic Disclosures
Challenges. 1. Sizing. 2. Proximal landing zone 3. Distal landing zone 4. Access vessels 5. Spinal cord ischemia 6. Endoleak
Disclosure I have the following potential conflicts of interest to report: Consulting: Medtronic, Gore Employment in industry Stockholder of a healthcare company Owner of a healthcare company Other(s)
Complex Thoracic and Abdominal Aortic Repair Using Hybrid Techniques
Complex Thoracic and Abdominal Aortic Repair Using Hybrid Techniques Tariq Almerey MD, January Moore BA, Houssam Farres MD, Richard Agnew MD, W. Andrew Oldenburg MD, Albert Hakaim MD Department of Vascular
Evaluation of Dynamic Intimal Flap Movement in Acute Stanford Type B Aortic Dissections (ATBD) and the Effects of Thoracic Endovascular Stent Grafting
Evaluation of Dynamic Intimal Flap Movement in Acute Stanford Type B Aortic Dissections (ATBD) and the Effects of Thoracic Endovascular Stent Grafting Frank R. Arko, III, MD, Jeko Madjarov, MD, Aaron Hurd,
Introducing the GORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL System
Introducing the GORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL System K. Oikonomou Department of Vascular Surgery Regensburg University Disclosures W.L. Gore & Associates Sponsored Presentation
Clinical Trials of Acute and Chronic Dissections. Gregory Landry MD
Clinical Trials of Acute and Chronic Dissections Gregory Landry MD No disclosures Acute vs chronic dissection: Definitions 1950s: Acute < 2 weeks, Chronic > 2 weeks 2013: European Interdisciplinary Consensus
DISCLOSURES ISOLATED DTA LESION? TYPE B DISSECTIONS TREATMENT OPTIONS
Endovascular Repair of Aortic Arch Pathologies; What is available/possible in the U.S. in 2018? Kaiser Permanente Endovascular Symposium 6/2/18 Sukgu M Han, MD, MS Assistant Professor of Clinical Surgery
Aortic Arch pathology options: Open,Hybrid, fenestration, Chimney or branched stent-graft?
Aortic Arch pathology options: Open,Hybrid, fenestration, Chimney or branched stent-graft? Chang Shu, M.D., Ph.D Vascular Surgery Center National Center for Cardiovascular Diseases. Fuwai Hospital, CAMS
UC SF. Disclosures. Thoracic Endovascular Aortic Repair 4/24/2009. Management of Acute Dissections: Is There Still a Role for Open Surgery?
UC SF Management of Acute Dissections: Is There Still a Role for Open Surgery? Darren B. Schneider, M.D. Assistant Professor of Surgery and Radiology Division of Vascular Surgery University of California
Endoanchor-assisted TEVAR
Endoanchor-assisted TEVAR May 29, 2015 NCVH2015 Grayson H. Wheatley III, MD Director of Aortic and Endovascular Surgery Associate Professor of Surgery Temple University School of Medicine Disclosures Consultant
Development of Stent Graft. Kato et al. Development of an expandable intra-aortic prothesis for experimental aortic dissection.
Development of Stent Graft Kato et al. Development of an expandable intra-aortic prothesis for experimental aortic dissection. ASAIO J 1993 The New England Journal of Medicine Downloaded from nejm.org
Title. Different arch branched devices are available, is morphology the. main criteria of choice? Ciro Ferrer, MD
Different arch branched devices are available, is morphology the Title main criteria of choice? Ciro Ferrer, MD Vascular Surgery Unit Sapienza University of Rome Disclosure Speaker name: Ciro Ferrer Proctoring/speaking
Performance of the conformable GORE TAG device in Type B aortic dissection from the GORE GREAT real world registry
University of Milan Thoracic Aortic Research Center Performance of the conformable GORE TAG device in Type B aortic dissection from the GORE GREAT real world registry Santi Trimarchi, MD, PhD Associate
Early Clinical Results with the Valiant Mona LSA Branch Stent-Graft
Early Clinical Results with the Valiant Mona LSA Branch Stent-Graft Frank R. Arko III, MD Professor of Cardiovascular Surgery Director, Endovascular Surgery Co-Director, Aortic Institute Carolinas Medical
Thoracic Aortic Research Center. University of Milan
University of Milan Thoracic Aortic Research Center Update on IRAD Santi Trimarchi, MD, PhD Associate Professor of Vascular Surgery, University of Milan Head, Unit of Vascular Surgery II Director, Thoracic
Influence of Oversizing on Outcome in Thoracic Endovascular Aortic Repair
738 J ENDOVASC THER 2013;20:738 745 CLINICAL INVESTIGATION Influence of Oversizing on Outcome in Thoracic Endovascular Aortic Repair Jip L. Tolenaar, MD 1,2 ; Frederik H.W. Jonker, MD, PhD 3 ; Frans L.
Percutaneous Approaches to Aortic Disease in 2018
Percutaneous Approaches to Aortic Disease in 2018 Wendy Tsang, MD, SM Assistant Professor, University of Toronto Toronto General Hospital, University Health Network Case 78 year old F Lower CP and upper
IMH/Penetrating Aortic Ulcers/ Saccular Aneurysms: How to manage and when to intervene
IMH/Penetrating Aortic Ulcers/ Saccular Aneurysms: How to manage and when to intervene UCSF Vascular Surgery Symposium 2018 Sukgu M Han, MD, MS Assistant Professor of Clinical Surgery Co-director, Comprehensive
Hybrid Repair of a Complex Thoracoabdominal Aortic Aneurysm
Hybrid Repair of a Complex Thoracoabdominal Aortic Aneurysm Virendra I. Patel MD MPH Assistant Professor of Surgery Massachusetts General Hospital Division of Vascular and Endovascular Surgery Disclosure
THE ENDURANT STENT GRAFT IN HOSTILE ANEURYSM NECK ANATOMY
THE ENDURANT STENT GRAFT IN HOSTILE ANEURYSM NECK ANATOMY Patrice Mwipatayi FCS (SA), MMed, FRACS Professor of Vascular surgery Royal Perth Hospital, University of Western Australia, Perth, WA Co-Authors:
UC SF An Algorithm to Choose Which Uncomplicated (Asymptomatic) Acute Type B Dissection Patients Should Undergo TEVAR. Disclosures.
An Algorithm to Choose Which Uncomplicated (Asymptomatic) Acute Type B Dissection Patients Should Undergo TEVAR Disclosures Royalties and research grant support from Cook Medical, Inc. Jade S. Hiramoto,
Animesh Rathore, MD 4/22/17. The Great Debate 45yo Man With Uncomplicated Acute TBAD: The Case For Medical Management
Animesh Rathore, MD 4/22/17 The Great Debate 45yo Man With Uncomplicated Acute TBAD: The Case For Medical Management Disclosures Just a young vascular surgeon who would like to keep his job My opponent
I have the following financial relationships to disclose:
Novel Approaches to Endovascular Management of Aortic Aneurysms Rodney A White, MD Medical Director, Vascular Services MemorialCare Heart & Vascular Institute Long Beach Memorial Hospital Long Beach, California
Challenges with Complex Anatomies Advancing Care in Endovascular Aortic Treatment
Challenges with Complex Anatomies Advancing Care in Endovascular Aortic Treatment Robert Y. Rhee, MD Chief, Vascular and Endovascular Surgery Director, Aortic Center Maimonides Medical Center Brooklyn,
Pioneering EVAR techniques in aortic dissection
Pioneering EVAR techniques in aortic dissection Jianing Yue, Weiguo Fu Department of Vascular Surgery Zhongshan Hospital Fudan University Shanghai, China LINC Asia-Pacific 2016 March 8-10, 2016 Hong Kong
THORACOABDOMINAL AORTIC ANEURYSMS HYBRID REPAIR
Update on Open and Endovascular Therapeutic Option for Aortic Repair CENTRE CARDIO-TORACIQUE DE MONACO Friday November 7 th, 2014 THORACOABDOMINAL AORTIC ANEURYSMS HYBRID REPAIR Roberto Chiesa Vascular
Combined Endovascular and Surgical Repair of Thoracoabdominal Aortic Pathology: Hybrid TEVAR
Combined Endovascular and Surgical Repair of Thoracoabdominal Aortic Pathology: Hybrid TEVAR William J. Quinones-Baldrich MD Professor of Surgery Director UCLA Aortic Center UCLA Medical Center Los Angeles,
High Risk Uncomplicated Type B Dissection
High Risk Uncomplicated Type B Dissection Ali Azizzadeh, MD, FACS Director, Vascular Surgery Vice Chair, Department of Surgery Associate Director, Heart Institute Cedars-Sinai Medical Center Los Angeles,
Aortic Neck Issues Associated Clinical Sequelae/Implications for Graft Choice
Aortic Neck Issues Associated Clinical Sequelae/Implications for Graft Choice Eric Verhoeven, MD, PhD, A. Katsargyris, MD Department of Vascular and Endovascular Surgery, Paracelsus Medical University,
UC SF Early Intervention in Type B Dissection: Results From the INSTEAD XL Trial. Acute Type B Dissection. Outline. Disclosures.
Early Intervention in Type B Dissection: Results From the INSTEAD XL Trial None Disclosures Jade S. Hiramoto, MD, MAS April 4, 2014 Outline Background Current treatment Results from INSTEAD trial Results
Do the Data Support Endovascular Therapy for Descending Thoracic AD? Woong Chol Kang, M.D.
Do the Data Support Endovascular Therapy for Descending Thoracic AD? Woong Chol Kang, M.D. Gil Hospital, Gachon University Incheon, Korea Classification of AD Acute vs. Chronic (2weeks) (IIIa, b) type
Is there a way to predict the risk in uncomplicated Type B aortic dissections? FRANS MOLL University Medical Centre Utrecht - Netherlands
Is there a way to predict the risk in uncomplicated Type B aortic dissections? FRANS MOLL University Medical Centre Utrecht - Netherlands Disclosures: - Consultant Philips Health Care - Best Doctors Overview
Understanding the Predictors of Aneurysmal Degeneration in Type B Dissection
Understanding the Predictors of Aneurysmal Degeneration in Type B Dissection A case example illustrating when early endovascular intervention may provide the best outcome. BY DITTMAR BÖCKLER, MD, PhD;
TEVAR for Chronic dissections: indications for TEVAR, long term results
TEVAR for Chronic dissections: indications for TEVAR, long term results J Sobocinski, R Azzaoui, B Maurel, R Spear, T Martin-Gonzalez, A Hertault, S Haulon Centre de l Aorte, Chirurgie vasculaire, Hôpital
COMPLICATIONS OF TEVAR
COMPLICATIONS OF TEVAR P. Bergeron, A.Petrosyan, F.Markatis, T.Abdulamit, J.-C. Trastour IMAD CONGRESS 2010 Liège Belgium BACKGROUND Stentgrafting is a recognized treatment for TAA & TAD and has been proposed
RETROGRADE BRANCH. Gustavo S. Oderich MD Professor of Surgery Director of Endovascular Therapy Division of Vascular and Endovascular Surgery
RETROGRADE BRANCH Gustavo S. Oderich MD Professor of Surgery Director of Endovascular Therapy Division of Vascular and Endovascular Surgery FACULTY DISCLOSURE Consulting* Cook Medical Inc., WL Gore Research
Abdominal and thoracic aneurysm repair
Abdominal and thoracic aneurysm repair William A. Gray MD Director, Endovascular Intervention Cardiovascular Research Foundation Columbia University Medical Center Abdominal Aortic Aneurysm Endografts
Optimal repair of acute aortic dissection
Optimal repair of acute aortic dissection Dept. of Vascular Surgery, The 2nd Xiang-Yale Hospital, Central-South University, China Hunan Major Vessels Diseases Clinical Center Chang Shu Email:changshu01@yahoo.com
ADSORB trial results: Is it enough to switch the paradigm?
ADSORB trial results: Is it enough to switch the paradigm? Jan Brunkwall, MD, PhD Professor and Chairman Complications to acute type B dissection Mortality Rupture Organ Ischemia Dilatation/Aneurysm Refractory
Taming The Aorta. David Minion, MD Program Director, Vascular Surgery University of Kentucky Medical Center Lexington, Kentucky, USA
Taming The Aorta David Minion, MD Program Director, Vascular Surgery University of Kentucky Medical Center Lexington, Kentucky, USA Faculty Disclosure Consulting: Endologix, Cook 1 Objectives Review the
IVUS Guided Case Review Case Performed by Frank R. Arko III, MD Charlotte, NC
IVUS Guided Case Review Case Performed by Frank R. Arko III, MD Charlotte, NC The opinions and clinical experiences presented herein are for informational purposes only. Dr. Arko is a paid consultant for
Role of Gender in TEVAR and EVAR results from the GREAT registry
Role of Gender in TEVAR and EVAR results from the GREAT registry Mauro Gargiulo Vascular Surgery University of Bologna - DIMES Policlinico S.Orsola-Malpighi Bologna, Italy mauro.gargiulo2@unibo.it Disclosure
Santi Trimarchi, MD, PhD Vascular Surgeon Thoracic Aortic Research Center, Director IRCCS Policlinico San Donato University of Milan
The Gore GREAT Registry: Update about a real life data collection Santi Trimarchi, MD, PhD Vascular Surgeon Thoracic Aortic Research Center, Director IRCCS Policlinico San Donato University of Milan Disclosures
Best surgical option for arch extension of type B dissection: the endovascular approach
Perspective Best surgical option for arch extension of type B dissection: the endovascular approach Toru Kuratani Department of Minimally Invasive Cardiovascular Medicine, Osaka University Graduate School
Treatment of complex thoracic cases Focus on the new Gore Active Control TAG device
Treatment of complex thoracic cases Focus on the new Gore Active Control TAG device Professor Christoph A. Nienaber The Royal Brompton and Harefield NHS Trust Cardiology and Aortic Centre C.Nienaber@rbht.nhs.uk
Left subclavian artery (LSA) coverage during
From Benchtop to Bedside With the Valiant Mona LSA Thoracic Stent Graft How physicians, engineers, and regulatory agencies can work together to best serve patients with new technologies. By Frank R. Arko,
Disclosures: Acute Aortic Syndrome. A. Michael Borkon, M.D. Director of CV Surgery Mid America Heart Institute Saint Luke s Hospital Kansas City, MO
Acute Aortic Syndrome Disclosures: A. Michael Borkon, M.D. Director of CV Surgery Mid America Heart Institute Saint Luke s Hospital Kansas City, MO No financial relationships to disclose 1 Acute Aortic
The role of false lumen intervention to promote remodelling via induced thrombosis the FLIRT concept
The role of false lumen intervention to promote remodelling via induced thrombosis the FLIRT concept Professor Christoph A. Nienaber The Royal Brompton and Harefield NHS Trust Cardiology and Aortic Centre
Neurological Complications of TEVAR. Frank J Criado, MD. Union Memorial-MedStar Health Baltimore, MD USA
ISES Online Neurological Complications of Frank J Criado, MD TEVAR Union Memorial-MedStar Health Baltimore, MD USA frank.criado@medstar.net Paraplegia Incidence is 0-4% after surgical Rx of TAAs confined
Improving Endograft Durability with EndoAnchors
Improving Endograft Durability with EndoAnchors William D. Jordan, Jr., M.D. John E. Skandalakis Chair in Surgery Professor and Chief Division of Vascular Surgery and Endovascular Therapy Emory University
State of Art Hybrid Approach
State of Art Hybrid Approach for Complex Aorta Diseases Won Ho Kim, MD Division of Cardiology, Eulji University Hospital Eulji University School of Medicine, Daejeon, Korea Introduction.Hybrid procedure
Current State of Thoracic Branch Devices and Ongoing Clinical Trials
Current State of Thoracic Branch Devices and Ongoing Clinical Trials Hiroo Takayama, MD, PhD Associate Professor of Surgery Director of Cardiovascular Institute Co-Director of Aortic Center NY Presbyterian/Columbia
The Role of Stent-Grafts in Marfan Syndrome
The Role of Stent-Grafts in Marfan Syndrome James H. Black, III, MD, FACS The David Goldfarb, MD, Associate Professor of Surgery Chief, Division of Vascular Surgery and Endovascular Therapy The Johns Hopkins
Vascular Intervention
10 : 389-393, 2001 B Vascular Intervention 1 1 2 1 1 1 1 3 2 1 1997 7 2000 4 B 29 19 10 50 84 66.1 stent graft S/G primary entry stenting S/G 12 4 2 1 1 40 mm 8 1 MOF 1 endoleak + 11 91.6% 10 stenting
Analysis of Risk Factors for Early Type I Endoleaks After Thoracic Endovascular Aneurysm Repair
673326JETXXX10.1177/1526602816673326Journal of Endovascular TherapyKanaoka et al research-article2016 Clinical Investigation Analysis of Risk Factors for Early Type I Endoleaks After Thoracic Endovascular
AORTIC DISSECTIONS Current Management. TOMAS D. MARTIN, MD, LAT Professor, TCV Surgery Director UF Health Aortic Disease Center University of Florida
AORTIC DISSECTIONS Current Management TOMAS D. MARTIN, MD, LAT Professor, TCV Surgery Director UF Health Aortic Disease Center University of Florida DISCLOSURES Terumo Medtronic Cook Edwards Cryolife AORTIC
Aortic Center of Excellence at Sentara
Gordon K. Stokes, MD, FACS Eastern Virginia Medical School Sentara Vascular Specialists Norfolk, VA Aortic Center of Excellence at Sentara April 25, 2014 Disclosures I have no disclosures relevant to this
Asymptomatic Radiology / Clinical data Report / Cohort bias Referral bias. UCSF Vascular Symposium April 7-9, Acute Aortic Dissection
Aortic Dissection: Natural History What is the Natural History of Aortic Dissection? UCSF Vascular Symposium April 7-9, 2011 Asymptomatic Radiology / Clinical data Report / Cohort bias Referral bias Stephen
Increased Flexibility of AneuRx Stent-Graft Reduces Need for Secondary Intervention Following Endovascular Aneurysm Repair
583 Increased Flexibility of AneuRx Stent-Graft Reduces Need for Secondary Intervention Following Endovascular Aneurysm Repair Frank R. Arko, MD; W. Anthony Lee, MD; Bradley B. Hill, MD; Paul Cipriano,
Acute dissections of the descending thoracic aorta (Debakey
Endovascular Treatment of Acute Descending Thoracic Aortic Dissections Nimesh D. Desai, MD, PhD, and Joseph E. Bavaria, MD Acute dissections of the descending thoracic aorta (Debakey type III or Stanford
What is the best treatment for False Lumen growth after type B Dissection
What is the best treatment for False Lumen growth after type B Dissection Nikolaos Tsilimparis, Fiona Rohlffs, Yuk Law, Sebastian Debus, Tilo Kölbel N. Tsilimparis, MD, PhD, FEBVS Deputy Head of German
Subject: Endovascular Stent Grafts for Disorders of the Thoracic Aorta
02-33000-29 Original Effective Date: 04/15/03 Reviewed: 07/26/18 Revised: 08/15/18 Subject: Endovascular Stent Grafts for Disorders of the Thoracic Aorta THIS MEDICAL COVERAGE GUIDELINE IS NOT AN AUTHORIZATION,
F. Terzi, S. Gianstefani, R. Fattori. cardiology and interventional cardiology unit, ospedali riuniti Marche nord, pesaro.
14_14 03/02/17 14.16 Pagina 101 Type B aortic dissection: it should Be TreaTed F. Terzi, S. Gianstefani, R. Fattori cardiology and interventional cardiology unit, ospedali riuniti Marche nord, pesaro.
The Current Status Of Endovascular Repair Of Ascending Aorta And Aortic Arch
The Current Status Of Endovascular Repair Of Ascending Aorta And Aortic Arch Tilo Kölbel German Aortic Center Dpt. of Vascular Medicine University Heart Center Hamburg Disclosures Research-grants, travelling,
Management of Acute Aortic Syndromes. M. Grabenwoger, MD Dept. of Cardiovascular Surgery Hospital Hietzing, Vienna, Austria
Management of Acute Aortic Syndromes M. Grabenwoger, MD Dept. of Cardiovascular Surgery Hospital Hietzing, Vienna, Austria I have nothing to disclose. Acute Aortic Syndromes Acute Aortic Dissection Type
La sindrome aortica acuta oggi
University of Milan Thoracic Aortic Research Center La sindrome aortica acuta oggi Santi Trimarchi, MD, PhD Professore Associato di Chirurgia Vascolare, Università degli Studi di Milano Direttore, Divisione
ENCORE, a Study to Investigate the Durability of Polymer EVAR with Ovation A Contemporary Review of 1296 Patients
ENCORE, a Study to Investigate the Durability of Polymer EVAR with Ovation A Contemporary Review of 1296 Patients The Ovation System is approved to treat infrarenal abdominal aortic aneurysms and is not
Modified candy-plug technique for chronic type B aortic dissection with aneurysmal dilatation: a case report
Kotani et al. Journal of Cardiothoracic Surgery (2017) 12:77 DOI 10.1186/s13019-017-0647-8 CASE REPORT Modified candy-plug technique for chronic type B aortic dissection with aneurysmal dilatation: a case
Treatment of acute type B aortic dissection: Current status
MEET Cannes, 18. - 21.06.2009 Treatment of acute type B aortic dissection: Current status Christoph A. Nienaber, MD, FACC University of Rostock Department of Internal Medicine, Cardiology christoph.nienaber@med.uni-rostock.de
Indications for use. Contraindications within the United States
Indications for use Indications within the United States The GORE TAG Thoracic Endoprosthesis is intended for endovascular repair of all lesions of the descending thoracic aorta, including: Isolated lesions
Animesh Rathore, MD 4/21/17. Penetrating atherosclerotic ulcers of aorta
Animesh Rathore, MD 4/21/17 Penetrating atherosclerotic ulcers of aorta Disclosures No financial disclosures Thank You Dr. Panneton for giving this lecture for me. I am stuck at Norfolk with an emergency
Antegrade Thoracic Stent Grafting during Repair of Acute Debakey I Dissection: Promotes Distal Aortic Remodeling and Reduces Late Open Re-operation
Antegrade Thoracic Stent Grafting during Repair of Acute Debakey I Dissection: Promotes Distal Aortic Remodeling and Reduces Late Open Re-operation Vallabhajosyula, P: Szeto, W; Desai, N; Pulsipher, A;
Type B Dissection Sub-Categories
Disclosure Nothing to disclose Type B Dissection On Whom to Operate on and When to do it Charles Eichler Professor, Department of Surgery Division of Vascular and Endovascular Surgery University of California
Endo-Bentall: Fact or Fiction?
Endo-Bentall: Fact or Fiction? Eric E. Roselli, MD Chief, Adult Cardiac Surgery Surgical Director, Aorta Center Heart and Vascular Institute, Cleveland Clinic Disclosures Bolton Cook Cryolife Edwards Gore
Current treatment of Aortic Aneurysms and Dissections. Adam Keefer, MD, FACS Sean Hislop, MD, FACS
Current treatment of Aortic Aneurysms and Dissections Adam Keefer, MD, FACS Sean Hislop, MD, FACS Patient 1 69 year old well-educated man with reoccurring pain in his upper abdomen and a pulsatile mass.
Hostile Neck During EVAR, The Role Of Endoanchores
Hostile Neck During EVAR, The Role Of Endoanchores Samer Koussayer, MD, FACS, RVT Prof, Al Faisal University Section Head and consultant Vascular & Endovascular Surgery Division King Faisal Specialist
Technique and Tips for Complicated AAA Cases with Stent Graft
Technique and Tips for Complicated AAA Cases with Stent Graft Seung-Woon Rha, MD, PhD FACC, FAHA, FESC, FSCAI, FAPSIC Cardiovascular Center, Korea University Guro Hospital Mar 15, 2018 LINC AP 2018 Endoleak;
WHICH PLACE FOR EMERGENT INTERVENTION IN COMPLICATED ACUTE TYPE B DISSECTION (ctbaod)
WHICH PLACE FOR EMERGENT INTERVENTION IN COMPLICATED ACUTE TYPE B DISSECTION (ctbaod) Epidemiology of type B Aortic Dissection TYPE B dissection: 0,5-2,1/100.000/year (40% of all dissection) Hospital mortality
History of the Powerlink System Design and Clinical Results. Edward B. Diethrich Arizona Heart Hospital Phoenix, AZ
History of the Powerlink System Design and Clinical Results Edward B. Diethrich Arizona Heart Hospital Phoenix, AZ Powerlink System: Unibody-Bifurcated Design Long Main Body Low-Porosity Proprietary eptfe
Preliminary Data from the Gore EXCLUDER Thoracoabdominal Branch Endoprosthesis Early Feasibility Study
Preliminary Data from the Gore EXCLUDER Thoracoabdominal Branch Endoprosthesis Early Feasibility Study Mark A Farber, MD Professor of Surgery and Radiology Director, UNC Aortic Network University of North
Accepted Manuscript. Is A More Extensive Operation Justified for Acute Type A Dissection Repair? Dr. Leonard N. Girardi
Accepted Manuscript Is A More Extensive Operation Justified for Acute Type A Dissection Repair? Dr. Leonard N. Girardi PII: S0022-5223(18)32552-2 DOI: 10.1016/j.jtcvs.2018.09.048 Reference: YMTC 13502
Ascending Thoracic Aorta: Postsurgical CT Evaluation
Ascending Thoracic Aorta: Postsurgical CT Evaluation Santiago Martinez Jimenez, MD GOALS Ascending Thoracic Aorta: Postsurgical CT Evaluation Santiago Martínez MD smartinez-jimenez@saint-lukes.org Saint
Accessi Iliaci Ostili
Alma Mater Studiorum Bologna University S.Orsola-Malpighi, Bologna, Italy Vascular Surgery Accessi Iliaci Ostili nel trattamento della patologia aortica E. Gallitto Iliac Navigations Alma Mater Studiorum
TEVAR for the Ascending Aorta
TEVAR for the Ascending Aorta Himanshu J. Patel MD Joe D. Morris Collegiate Professor Section Head, Adult Cardiac Surgery University of Michigan Frankel Cardiovascular Center Disclosures Himanshu J. Patel
Residual Dissection and False Lumen Aneurysm After TEVAR
WHAT WOULD YOU DO? Residual Dissection and False Lumen Aneurysm After MODERATOR: MARK FARBER, MD PANEL: YAZAN DUWAYRI, MD; MATTHEW J. EAGLETON, MD; WILLIAM D. JORDAN Jr, MD; TILO KÖLBEL, MD, PhD; AND ERIC
Early outcomes of acute retrograde dissection in the aortic arch and the ascending aorta data from IRAD
Early outcomes of acute retrograde dissection in the aortic arch and the ascending aorta data from IRAD Foeke JH Nauta, MD, PhD Resident Cardiothoracic Surgery, Academic Medical Center, Amsterdam Disclosure